Molecular Assemblies harnesses natural, DNA-synthesizing enzymes for commercial production. In this article, Mike Kamdar discusses how fully enzymatic synthesis for synthetic DNA will transform life sciences and medicine by accelerating the development of innovative therapies and vaccines, as well as how DNA could solve many issues in data storage.
“To our knowledge, we are the first industry group to store and retrieve digital information in DNA using enzymatic synthesis in a cost-effective, sustainable, and scalable way.” – Mike Kamdar, President and CEO of Molecular Assemblies
